Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Dermapharm Holding SE

DMP.DE ✗ NOT COMPLIANT ☆ Track — members

Xetra · Healthcare · Pharmaceuticals ·

Germany Mid Cap Analyst: BUY

Last Close

$45.81

▼ -0.88%

Market Cap $2.26B · Vol 25.50K

Key Metrics

P/E Ratio

14.79

FWD: 13.79

Market Cap

$2.26B

Mid Cap

Div Yield

2.22%

Annual dividend

EPS Growth

+9.67%

YoY

RSI (14)

41.48

Momentum

Beta

0.83

vs Market

52W High

$60.04

24.26% below

52W Low

$36.67

23.89% above

Volume

25.50K

Avg 21.30K

P/B

3.05

Price-to-book

ROE

20.39%

Return on equity

Free Float

10.70%

Public shares

Shariah Compliance8 STANDARDS

✗ Dermapharm Holding SE (DMP.DE) stock is currently not Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See which standards it fails, the exact ratios behind the verdict, and halal alternatives. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does DMP.DE pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-2.22%

-8.55%

-21.58%

+7.32%

YTD

+0.64%

+20.18%

-2.20%

-45.94%

Financials & Valuation

TTM · Annual

Total Revenue	$1.37B
Net Income	$154.27M
Revenue Growth (YoY)	N/A
Gross Margin	60.88%
Operating Margin	20.95%
Net Profit Margin	11.27%
ROE	20.39%
ROA · ROIC	8.60% · 10.04%

P/E Ratio	14.79
Forward P/E (FY1)	13.79
PEG Ratio	0.98
P/S	1.82
P/B	3.05
P/FCF	15.20
EPS Growth	+9.67%
Outstanding Shares	49.54M

Technical Indicators

50-Day SMA	$51.15
200-Day SMA	$47.75
RSI (14)	41.48
Beta	0.83
52-Week High	$60.04
52-Week Low	$36.67

Volume Today	25.50K
Avg Daily Volume (30D)	21.30K
Relative Volume	1.20x
Volatility (10D)	12.52
Volatility (30D)	22.98
Free Float	10.70%

Analyst Consensus

BUY

Current Price $45.81

Mean Target $58.13

52W Low$36.67 52W High$60.04

Current

Target

$36.67 $60.04

Current Analyst target

+26.89% upside potential · 5 analysts

Identifiers

ExchangeXetra

FIGIBBG00JRJQX60

ISINDE000A2GS5D8

CountryGermany

Sub-IndustryPharmaceuticals (NEC)

Earnings DateNov 13, 2026

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

LLY Eli Lilly and Co -2.39% JNJ Johnson & Johnson -0.66% ABBV Abbvie Inc -0.54% NVS Novartis AG -0.55% NOVN.S Novartis AG -1.05%

Company Profile

Dermapharm Holding SE is a Germany-based company engaged in manufacturing of patent-free branded pharmaceuticals. The Company operates through two segments: Branded pharmaceuticals and other healthcare products, which includes in-house development, in-house production, and distribution of branded pharmaceuticals and other healthcare products, and Parallel import business, which operates under the axicorp brand. It holds around 950 marketing authorizations for more than 250 active pharmaceutical ingredients, which are marketed as pharmaceuticals, dietary supplements or supplemental balanced diets. The Company offers its products through a number of brands, including Dekristol, Ampho Moronal, Keltican, Tromcardin, among others. It is active primarily in Germany, Switzerland and Austria. Additionally, it operates production facility in Germany. Trommsdorff & GmbH Co KG is a subsidiary of the Company.